Android app on Google Play

Canaccord Genuity Reiterates Bullish Stance on Nu Skin (NUS)

May 17, 2012 8:53 AM EDT Send to a Friend
Get Alerts NUS Hot Sheet
Price: $44.72 -1.26%

Rating Summary:
    4 Buy, 3 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 3 | Down: 4 | New: 7
Trade NUS Now!
Join SI Premium – FREE
Canaccord Genuity reiterated their Buy rating and $66 price target on Nu Skin Enterprises (NYSE: NUS) saying "focus can now return to the fundamentals and the enormous success of product launches occurring this quarter in the Greater China and SE Asia regions."

The firm sees a powerful product cycle, coupled with a concerted effort to improve margins that should drive above-average EPS growth.

Canaccord is raising F2012 and F2013 EPS estimates to $3.03 and $3.45 from $2.95 and $3.40, respectively, to reflect the stronger-than-expected launches this quarter.

NOTE: Shares of NUS have been under pressure as they've been tied to David Einhorn's potential short on Herbalife Ltd. (NYSE: HLF) and speculation he would mention it at yesterday's Ira Sohn conference. Einhorn did not mention the stock.

For an analyst ratings summary and ratings history on Nu Skin Enterprises click here. For more ratings news on Nu Skin Enterprises click here.

Shares of Nu Skin Enterprises closed at $46.46 yesterday.




You May Also Be Interested In


Related Categories

Analyst Comments, Trader Talk

Related Entities

Greenlight Capital, David Einhorn

Add Your Comment